Telepsychiatry, telemental health, telepsychology, teletherapy --- whatever you call it, it is now required in the era of the COVID‐19 pandemic. "We should be doing it immediately; the more, the better," said Robert Caudill, M.D., a member of the American Psychiatric Association\'s Committee on Telepsychiatry. "It\'s exploded in the past week, obviously," he told *ADAW* in a Zoom interview on March 23. But he thinks it should be the norm.

"Our original problem was we ignored the telephone; we treated it as if it wasn\'t a big deal," said Caudill. Patients thought they could talk to the psychiatrist on the phone for free, so the phone was dropped as an option. Now, like email and text, technology is threatening to take away income. But instead, psychiatrists should embrace the technologies of video and audio, and bill for them like regular, in‐person treatment. "I think video and audio most closely simulates what we do in person," with all senses, except for the sense of smell, he said. Psychiatrists and patients don\'t touch; there is no physical exam, so mental health care is ideal for telemedicine.

Insurance reimbursement needs to be fixed, he admits, but this has to be done on the state level. Caudill, a Kentucky native, said the state requires that anything that can be done in person needs to have the same payment rate via telemedicine (excluding Medicare).

He recommends that therapists look not at the screen, where the patient is, but at the camera. It\'s also possible to type notes easily without the patient seeing. "One of the big complaints when electronic health records came out was that patients thought doctors spent too long looking at a computer screen," Caudill said. "**"We\'ve done some crazy things because of the way reimbursement works. If you call up your primary care doctor with a problem, they\'ll say you have to come into the office to be seen. Why is that? So that they can get paid."**Robert Caudill, M.D."

Isn\'t it therapeutically better for the therapy visit to be face to face? "Who says?" said Caudill. "Why is that a rule?"

Again, he blames the problem --- which began with not doing telephone therapy --- on insurance. "We\'ve done some crazy things because of the way reimbursement works," said Caudill. "If you call up your primary care doctor with a problem, they\'ll say you have to come into the office to be seen. Why is that? So that they can get paid."

Psychiatrists already have many patients who are self‐pay, even if they have insurance, because they don\'t want a record of the transaction, noted Caudill.

Controlled substances {#adaw32673-sec-0002}
=====================

For years, professionals treating patients with buprenorphine have been trying to eliminate the Ryan Haight Act\'s restrictions on induction visits for controlled substances, which require a face‐to‐face evaluation with a health care provider. Because of COVID‐19, the Drug Enforcement Administration has temporarily removed that requirement, now allowing this visit to be done by telemedicine.

Buprenorphine induction isn\'t the only service affected. As child and adolescent psychiatrist Shabana Khan, M.D., pointed out in an interview with *ADAW* last week, it also means that induction visits for attention‐deficit/hyperactivity disorder (ADHD) medications, most of which are controlled substances, can be done by telemedicine.

"One of the regulatory hurdles in our field has been the Ryan Haight Act, which is very relevant to child and adolescent treatment," said Khan, who is an assistant professor in the Department of Child and Adolescent Psychiatry and director of child and adolescent telepsychiatry at NYU Langone. "The first‐line treatment for ADHD is stimulants, so it has been a limitation to have to conduct an in‐person exam before prescribing these."

Prescriptions can now be made after a thorough assessment through a live interactive video, she said.

Mark Willenbring, M.D., founder and CEO of Alltyr in St. Paul, Minnesota, also is a fan of telemedicine. "I\'m doing medical visits primarily, a combination of psychotherapy and medication," he said. While three therapists work with patients, they are now working remotely as well. "I have not seen anyone in person" since the COVID‐19 isolation started, he said. "Patients are very appreciative of it."

The only problem is "a little bit of degradation of the internet," he said. "Sometimes I need to switch to audio only." He uses doxy.me, an encrypted medical video program.

What is different between therapy in person and therapy remotely? "Basically, you do the same thing," said Willenbring, This applies to new patients, too.

Financial problems of patients {#adaw32673-sec-0003}
==============================

More than half of Willenbring\'s patients are private pay, not insurance. Like all businesses, he is concerned about their livelihoods, and whether they will end up with too much financial difficulty to pay. "We do make arrangements when we can," said Willenbring. "Already 20% of my practice is pro bono."

Electronic prescribing of controlled substances, also now allowed, has been vital, said Willenbring. "It\'s not only buprenorphine; I\'m talking about stimulants for ADHD, diazepam for anxiety."

There are some patients who would clearly prefer an in‐person visit, but this isn\'t an option now. The engagement with therapists does vary from patient to patient, said Willenbring. Some patients have been seen weekly for some time, and are now going down to every other week or, eventually, monthly, he said.

There are also benefits for rural areas. "If the patient is in a mental health clinic in a rural county, and there\'s a nurse on‐site, the nurse can help facilitate things like measuring blood pressure, height and weight, and to conduct urine testing," said Khan. "We can collaborate with the pediatrician" via audio or video, and there are also ways to monitor patient vital signs remotely.

The one aspect of addiction telemedicine that hasn\'t been worked out is urine testing, said Willenbring. Sending patients to a lab isn\'t viable, because the practice does point‐of‐service testing with cups in house. "These cups are very good; they test for 14 drugs," said Willenbring, adding that he does them at every visit.

*Editor\'s note:* None of these relaxed rules applies to methadone patients, whose main benefit is going to be increased take‐homes (see "DEA, SAMHSA relax OTP/OBOT regulations due to COVID‐19," *ADAW*, March 23, <https://onlinelibrary.wiley.com/doi/full/10.1002/adaw.32664>)

For the DEA announcement, see <https://www.samhsa.gov/sites/default/files/programs_campaigns/medication_assisted/dea-information-telemedicine.pdf>.

For Medicare payment information, see <https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet>.
